Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction me...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 116; no. 22; pp. e111 - e117
Main Authors White, Helen E., Matejtschuk, Paul, Rigsby, Peter, Gabert, Jean, Lin, Feng, Lynn Wang, Y., Branford, Susan, Müller, Martin C., Beaufils, Nathalie, Beillard, Emmanuel, Colomer, Dolors, Dvorakova, Dana, Ehrencrona, Hans, Goh, Hyun-Gyung, El Housni, Hakim, Jones, Dan, Kairisto, Veli, Kamel-Reid, Suzanne, Kim, Dong-Wook, Langabeer, Stephen, Ma, Edmond S.K., Press, Richard D., Romeo, Giuliana, Wang, Lihui, Zoi, Katerina, Hughes, Timothy, Saglio, Giuseppe, Hochhaus, Andreas, Goldman, John M., Metcalfe, Paul, Cross, Nicholas C.P.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 25.11.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials.
AbstractList Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials.
Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials.Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia, but there is substantial variation in the real-time quantitative polymerase chain reaction methodologies used by different testing laboratories. To help improve the comparability of results between centers we sought to develop accredited reference reagents that are directly linked to the BCR-ABL international scale. After assessment of candidate cell lines, a reference material panel comprising 4 different dilution levels of freeze-dried preparations of K562 cells diluted in HL60 cells was prepared. After performance evaluation, the materials were assigned fixed percent BCR-ABL/control gene values according to the International Scale. A recommendation that the 4 materials be established as the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL translocation by real-time quantitative polymerase chain reaction was approved by the Expert Committee on Biological Standardization of the World Health Organization in November 2009. We consider that the development of these reagents is a significant milestone in the standardization of this clinically important test, but because they are a limited resource we suggest that their availability is restricted to manufacturers of secondary reference materials.
Author Zoi, Katerina
Colomer, Dolors
White, Helen E.
Kairisto, Veli
Dvorakova, Dana
Press, Richard D.
Goh, Hyun-Gyung
Kamel-Reid, Suzanne
Cross, Nicholas C.P.
Langabeer, Stephen
Wang, Lihui
El Housni, Hakim
Saglio, Giuseppe
Matejtschuk, Paul
Kim, Dong-Wook
Rigsby, Peter
Ehrencrona, Hans
Gabert, Jean
Romeo, Giuliana
Ma, Edmond S.K.
Lynn Wang, Y.
Lin, Feng
Jones, Dan
Müller, Martin C.
Goldman, John M.
Beaufils, Nathalie
Beillard, Emmanuel
Hochhaus, Andreas
Metcalfe, Paul
Branford, Susan
Hughes, Timothy
Author_xml – sequence: 1
  givenname: Helen E.
  surname: White
  fullname: White, Helen E.
  organization: National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, United Kingdom
– sequence: 2
  givenname: Paul
  surname: Matejtschuk
  fullname: Matejtschuk, Paul
  organization: National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, United Kingdom
– sequence: 3
  givenname: Peter
  surname: Rigsby
  fullname: Rigsby, Peter
  organization: National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, United Kingdom
– sequence: 4
  givenname: Jean
  surname: Gabert
  fullname: Gabert, Jean
  organization: Biochemistry and Molecular Laboratory, Hopital Nord–Assistance Publique–Hôpitaux de Marseille, Marseille, France
– sequence: 5
  givenname: Feng
  surname: Lin
  fullname: Lin, Feng
  organization: National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, United Kingdom
– sequence: 6
  givenname: Y.
  surname: Lynn Wang
  fullname: Lynn Wang, Y.
  organization: Molecular Hematopathology Laboratory, Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY
– sequence: 7
  givenname: Susan
  surname: Branford
  fullname: Branford, Susan
  organization: Department of Molecular Pathology, SA Pathology and the University of Adelaide, Adelaide, Australia
– sequence: 8
  givenname: Martin C.
  surname: Müller
  fullname: Müller, Martin C.
  organization: III Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany
– sequence: 9
  givenname: Nathalie
  surname: Beaufils
  fullname: Beaufils, Nathalie
  organization: Biochemistry and Molecular Laboratory, Hopital Nord–Assistance Publique–Hôpitaux de Marseille, Marseille, France
– sequence: 10
  givenname: Emmanuel
  surname: Beillard
  fullname: Beillard, Emmanuel
  organization: MolecularMD, Portland, OR
– sequence: 11
  givenname: Dolors
  surname: Colomer
  fullname: Colomer, Dolors
  organization: Unitat d'hematopatologia, Hospital Clinic, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
– sequence: 12
  givenname: Dana
  surname: Dvorakova
  fullname: Dvorakova, Dana
  organization: University Hospital Brno and Masaryk University, Center of Molecular Biology and Gene Therapy, Brno, Czech Republic
– sequence: 13
  givenname: Hans
  surname: Ehrencrona
  fullname: Ehrencrona, Hans
  organization: Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
– sequence: 14
  givenname: Hyun-Gyung
  surname: Goh
  fullname: Goh, Hyun-Gyung
  organization: Molecular Genetics Research Institute, The Catholic University of Korea, Seoul, Republic of Korea
– sequence: 15
  givenname: Hakim
  surname: El Housni
  fullname: El Housni, Hakim
  organization: Medical Genetics Department, Erasme Hospital, Brussels, Belgium
– sequence: 16
  givenname: Dan
  surname: Jones
  fullname: Jones, Dan
  organization: Molecular Diagnostics Laboratory, The University of Texas M. D. Anderson Cancer Center, Houston, TX
– sequence: 17
  givenname: Veli
  surname: Kairisto
  fullname: Kairisto, Veli
  organization: Turku University Hospital Laboratories, TYKSLAB, Turku, Finland
– sequence: 18
  givenname: Suzanne
  surname: Kamel-Reid
  fullname: Kamel-Reid, Suzanne
  organization: Department of Pathology, The University Health Network, Toronto, ON
– sequence: 19
  givenname: Dong-Wook
  surname: Kim
  fullname: Kim, Dong-Wook
  organization: Molecular Genetics Research Institute, The Catholic University of Korea, Seoul, Republic of Korea
– sequence: 20
  givenname: Stephen
  surname: Langabeer
  fullname: Langabeer, Stephen
  organization: Cancer Molecular Diagnostics, Central Pathology Laboratory, St James's Hospital, Dublin, Ireland
– sequence: 21
  givenname: Edmond S.K.
  surname: Ma
  fullname: Ma, Edmond S.K.
  organization: Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong
– sequence: 22
  givenname: Richard D.
  surname: Press
  fullname: Press, Richard D.
  organization: Department of Pathology, Oregon Health and Science University, Portland, OR
– sequence: 23
  givenname: Giuliana
  surname: Romeo
  fullname: Romeo, Giuliana
  organization: Molecular Haematology Laboratory, PathWest Laboratory Medicine, Royal Perth Hospital, Perth, Australia
– sequence: 24
  givenname: Lihui
  surname: Wang
  fullname: Wang, Lihui
  organization: Department of Haematology, Royal Liverpool University Hospital, Liverpool, United Kingdom
– sequence: 25
  givenname: Katerina
  surname: Zoi
  fullname: Zoi, Katerina
  organization: Haematology Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece
– sequence: 26
  givenname: Timothy
  surname: Hughes
  fullname: Hughes, Timothy
  organization: Department of Haematology, SA Pathology and the University of Adelaide, Adelaide, Australia
– sequence: 27
  givenname: Giuseppe
  surname: Saglio
  fullname: Saglio, Giuseppe
  organization: Department of Clinical and Biological Science, University of Turin, Turin, Italy
– sequence: 28
  givenname: Andreas
  surname: Hochhaus
  fullname: Hochhaus, Andreas
  organization: Department Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany
– sequence: 29
  givenname: John M.
  surname: Goldman
  fullname: Goldman, John M.
  organization: Department of Haematology, Imperial College Academic Health Science Centre, Hammersmith Campus, London, United Kingdom; and
– sequence: 30
  givenname: Paul
  surname: Metcalfe
  fullname: Metcalfe, Paul
  email: ncpc@soton.ac.uk, Paul.Metcalfe@nibsc.hpa.org.uk
  organization: National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, United Kingdom
– sequence: 31
  givenname: Nicholas C.P.
  surname: Cross
  fullname: Cross, Nicholas C.P.
  organization: National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20720184$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-139355$$DView record from Swedish Publication Index
BookMark eNqFkc1u1DAUhS1URKeFN0DIOzYN-D8JC6TpUNpKI4pG_Cwtj3PTMUrsqe2AaF-eTDNlwYKubNnfObLvd4QOfPCA0EtK3lBasbfrLoSmYISSgqiC1VQJ-gTNqGRVQQgjB2hGyHgj6pIeoqOUfhBCBWfyGTpkpByDlZihu7OUzbpzadODzzi0OG8Aty6mjL-H2DX4AkyXN_gqXhvvbk12weNLnyH6-73p8Dl4yM7iFbQQwVvAn42HDrch4pvB-OzyFBvbTxerYn66xP3q0_w5etqaLsGL_XqMvn48-7K4KJZX55eL-bKwUrBcCKibRppSkspIVralNE3TgmhZzQUoq0Aoxi0Zj6QqpWo5r6uyrrk1RFUE-DE6mXrTL9gOa72Nrjfxtw7G6Q_u21yHeK2HQVNecylH_PWEb2O4GSBl3btkoevGT4Uh6VoKWXNG-aNkRYVQipByJF_tyWHdQ_P3CQ8iRuDdBNgYUorQarufWo7GdZoSvbOu763rnXVNlJ6sj2HxT_ih_5HY-ykG4_B_Oog6Wbfz17gINusmuP8X_AHc48YR
CitedBy_id crossref_primary_10_1007_s00277_015_2315_1
crossref_primary_10_1111_j_1365_2141_2012_09203_x
crossref_primary_10_1080_21678707_2019_1652598
crossref_primary_10_1038_s41375_023_02048_y
crossref_primary_10_47183_mes_2024_244
crossref_primary_10_1016_j_prp_2012_05_008
crossref_primary_10_1016_j_bdq_2017_01_001
crossref_primary_10_5339_connect_2014_24
crossref_primary_10_1586_14737159_2013_835573
crossref_primary_10_1111_ijlh_12600
crossref_primary_10_1586_14737159_2014_927311
crossref_primary_10_1080_10428194_2016_1190974
crossref_primary_10_3390_genes13060948
crossref_primary_10_5858_arpa_2014_0522_LE
crossref_primary_10_1016_j_jmoldx_2013_05_010
crossref_primary_10_5858_arpa_2021_0121_OA
crossref_primary_10_1038_leu_2012_104
crossref_primary_10_1371_journal_pone_0265278
crossref_primary_10_1007_s40291_020_00485_4
crossref_primary_10_1007_s00103_016_2315_x
crossref_primary_10_1016_j_clinbiochem_2014_05_067
crossref_primary_10_1177_2040620716657994
crossref_primary_10_3324_haematol_2019_240739
crossref_primary_10_1016_j_jmoldx_2016_05_008
crossref_primary_10_1097_PAT_0b013e32834a9da8
crossref_primary_10_1128_JCM_02254_14
crossref_primary_10_1177_2374289517708309
crossref_primary_10_1111_bjh_14557
crossref_primary_10_1182_asheducation_2011_1_128
crossref_primary_10_1007_s00277_018_3570_8
crossref_primary_10_1177_20406207241259678
crossref_primary_10_1158_1078_0432_CCR_17_0962
crossref_primary_10_1007_s10147_011_0328_x
crossref_primary_10_1016_j_banm_2023_04_001
crossref_primary_10_1515_cclm_2016_0927
crossref_primary_10_1007_s00277_012_1468_4
crossref_primary_10_1111_ijlh_12353
crossref_primary_10_1002_cncr_29053
crossref_primary_10_1111_ejh_13238
crossref_primary_10_1016_j_yamp_2018_07_006
crossref_primary_10_1182_asheducation_2016_1_156
crossref_primary_10_1016_j_leukres_2018_08_021
crossref_primary_10_1373_clinchem_2013_204941
crossref_primary_10_1038_s41375_022_01607_z
crossref_primary_10_1182_blood_2011_07_365007
crossref_primary_10_1002_pros_23710
crossref_primary_10_1016_j_mam_2019_10_005
crossref_primary_10_1016_j_clinbiochem_2018_04_015
crossref_primary_10_1038_s41375_024_02275_x
crossref_primary_10_1097_HS9_0000000000000496
crossref_primary_10_1111_bjh_17521
crossref_primary_10_1016_j_jmoldx_2013_10_007
crossref_primary_10_1128_JCM_01628_15
crossref_primary_10_1016_j_hoc_2011_09_003
crossref_primary_10_1097_PAT_0b013e32834e4203
crossref_primary_10_5858_arpa_2011_0136_OA
crossref_primary_10_1111_ijlh_12919
crossref_primary_10_1016_j_cca_2011_10_022
crossref_primary_10_1016_j_jmoldx_2013_02_004
crossref_primary_10_3892_ol_2017_7720
crossref_primary_10_1038_nrg_2017_44
crossref_primary_10_1016_j_clml_2011_01_001
crossref_primary_10_1016_j_lrr_2023_100373
crossref_primary_10_1111_bjh_13966
crossref_primary_10_1186_s12920_023_01607_7
crossref_primary_10_1038_leu_2015_29
crossref_primary_10_1111_bjh_18046
crossref_primary_10_1016_j_cca_2013_10_016
crossref_primary_10_1182_bloodadvances_2022009379
crossref_primary_10_1373_clinchem_2012_196477
crossref_primary_10_3390_cancers12113287
crossref_primary_10_3109_10428194_2015_1122779
crossref_primary_10_3390_cancers13215470
crossref_primary_10_1186_s40064_016_2258_6
crossref_primary_10_5858_arpa_2013_0754_OA
crossref_primary_10_1111_ijlh_12541
crossref_primary_10_1373_clinchem_2012_185132
crossref_primary_10_1007_s11899_011_0082_1
crossref_primary_10_1111_ijlh_14320
crossref_primary_10_1038_leu_2016_197
crossref_primary_10_1016_S0140_6736_13_62120_0
crossref_primary_10_1021_acsomega_2c07885
crossref_primary_10_1002_cam4_801
crossref_primary_10_1515_cclm_2019_1283
crossref_primary_10_1007_s00216_024_05492_6
crossref_primary_10_1038_ejhg_2013_145
crossref_primary_10_1038_leu_2014_217
crossref_primary_10_1038_s41375_022_01612_2
crossref_primary_10_1016_j_exphem_2019_12_002
crossref_primary_10_1016_j_jmoldx_2019_03_002
crossref_primary_10_18632_oncotarget_333
crossref_primary_10_1002_jcla_22612
crossref_primary_10_1007_s11899_013_0192_z
crossref_primary_10_1309_LMSE7M60TABHDNEV
crossref_primary_10_1038_bcj_2011_10
crossref_primary_10_1016_j_jmoldx_2013_04_007
crossref_primary_10_1080_16078454_2023_2256199
crossref_primary_10_1016_S1773_035X_17_30162_4
crossref_primary_10_3109_10428194_2012_659734
crossref_primary_10_1111_ijlh_12274
crossref_primary_10_3109_10428194_2013_797085
crossref_primary_10_1111_ijlh_12556
crossref_primary_10_1371_journal_pone_0207170
crossref_primary_10_3390_diseases9020035
crossref_primary_10_1016_j_plabm_2021_e00210
crossref_primary_10_1111_j_1365_2141_2011_08603_x
crossref_primary_10_1016_j_mayocp_2015_08_010
crossref_primary_10_1634_theoncologist_2015_0337
crossref_primary_10_1002_cncr_32940
crossref_primary_10_1038_leu_2016_90
crossref_primary_10_47429_lmo_2023_13_4_356
crossref_primary_10_1182_blood_2014_03_566323
Cites_doi 10.1182/asheducation-2009.1.371
10.2353/jmoldx.2007.060134
10.1182/blood.V97.6.1560
10.1200/JCO.2009.25.0779
10.1016/j.blre.2005.01.008
10.1182/blood-2006-01-0092
10.1038/leu.2009.168
10.1001/archinte.1994.00420030084008
10.1182/blood-2008-04-150680
10.1016/j.beha.2009.04.001
10.1038/sj.leu.2404983
10.6004/jnccn.2009.0065
10.1056/NEJMoa030513
10.1111/j.1365-2141.1995.tb05257.x
10.1111/j.1365-2141.1992.tb06947.x
10.1016/0140-6736(93)92619-5
10.1038/sj.leu.2404388
10.1046/j.1365-2141.1997.4683272.x
10.3324/haematol.11172
10.1046/j.1365-2141.1999.01749.x
10.1038/sj.leu.2401566
10.1038/sj.leu.2404716
10.1038/sj.leu.2403135
ContentType Journal Article
Copyright 2010 American Society of Hematology
Copyright_xml – notice: 2010 American Society of Hematology
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TM
8FD
FR3
P64
RC3
ADTPV
AOWAS
DF2
DOI 10.1182/blood-2010-06-291641
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
SwePub
SwePub Articles
SWEPUB Uppsala universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Genetics Abstracts
Engineering Research Database
Technology Research Database
Nucleic Acids Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitleList CrossRef
MEDLINE

MEDLINE - Academic
Genetics Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage e117
ExternalDocumentID oai_DiVA_org_uu_139355
20720184
10_1182_blood_2010_06_291641
S0006497120310338
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.55
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6I.
6J9
9M8
AAEDW
AAFTH
AAXUO
ABOCM
ABVKL
ACGFO
ADBBV
AENEX
AFFNX
AFOSN
AHPSJ
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
IH2
K-O
KQ8
L7B
LSO
MJL
N4W
N9A
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
W2D
W8F
WH7
WOQ
WOW
X7M
YHG
YKV
ZA5
0R~
AALRI
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AITUG
AKBMS
AKRWK
AKYEP
AMRAJ
CITATION
H13
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TM
8FD
FR3
P64
RC3
.GJ
AAQQT
AAYWO
ADTPV
AI.
AOWAS
C1A
DF2
EFKBS
J5H
MVM
OHT
VH1
WHG
ZGI
ZXP
ID FETCH-LOGICAL-c542t-4e9dd5a7508a527f75addfe4f2934e6c6e4623c0fe456756f33987993ca0680e3
ISSN 0006-4971
1528-0020
IngestDate Thu Aug 21 07:17:30 EDT 2025
Thu Jul 10 17:31:54 EDT 2025
Fri Jul 11 06:50:15 EDT 2025
Thu Apr 03 06:53:39 EDT 2025
Tue Jul 01 04:18:30 EDT 2025
Thu Apr 24 23:12:47 EDT 2025
Fri Feb 23 02:44:39 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 22
Language English
License This article is made available under the Elsevier license.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c542t-4e9dd5a7508a527f75addfe4f2934e6c6e4623c0fe456756f33987993ca0680e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://dx.doi.org/10.1182/blood-2010-06-291641
PMID 20720184
PQID 814466007
PQPubID 23479
ParticipantIDs swepub_primary_oai_DiVA_org_uu_139355
proquest_miscellaneous_954593213
proquest_miscellaneous_814466007
pubmed_primary_20720184
crossref_citationtrail_10_1182_blood_2010_06_291641
crossref_primary_10_1182_blood_2010_06_291641
elsevier_sciencedirect_doi_10_1182_blood_2010_06_291641
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-11-25
PublicationDateYYYYMMDD 2010-11-25
PublicationDate_xml – month: 11
  year: 2010
  text: 2010-11-25
  day: 25
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Blood
PublicationTitleAlternate Blood
PublicationYear 2010
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Baccarani, Cortes, Pane (bib2) 2009; 27
Ottmann, Pfeifer (bib3) 2009
Lion, Henn, Gaiger, Kalhs, Gadner (bib25) 1993; 341
O'Brien, Berman, Borghaei (bib1) 2009; 7
Raanani, Dazzi, Sohal (bib22) 1997; 99
Cross (bib5) 2009; 22
World Health Organization. (bib14) 2006; 932
Müller, Erben, Saglio (bib26) 2008; 22
Branford, Cross, Hochhaus (bib10) 2006; 20
Branford, Fletcher, Cross (bib11) 2008; 112
Zhang, Grenier, Nwachukwu, Wei, Lipton, Kamel-Reid (bib6) 2007; 9
Müller, Saglio, Lin (bib7) 2007; 92
Hirsh, Poller (bib12) 1994; 154
Gabert, Beillard, van der Velden (bib4) 2003; 17
Hughes, Branford (bib16) 2006; 20
White HE, Cross NCP, Freeze dried cell lines as reference materials for standardisation of BCR-ABL RQPCR methods: report of a field trial evaluation., Accessed June 23, 2010, 1-53. 2008. www.ngrl.org.uk/Wessex/downloads/pdf/NGRLW_NIBSC_BCR_ABL_1.0.pdf.
Cross, Melo, Feng, Goldman (bib18) 1994; 8
Malinge, Mahon, Delfau (bib23) 1992; 82
Hughes, Deininger, Hochhaus (bib8) 2006; 108
Hochhaus, Lin, Reiter (bib21) 1995; 91
Olavarria, Kanfer, Szydlo (bib24) 2001; 97
Branford, Hughes, Rudzki (bib19) 1999; 107
Saldanha, Silvy, Beaufils (bib15) 2007; 21
Müller, Cross, Erben (bib13) 2009; 23
Hughes, Kaeda, Branford (bib9) 2003; 349
Emig, Saussele, Wittor (bib20) 1999; 13
Hochhaus (2019111822375024500_B21) 1995; 91
Ottmann (2019111822375024500_B3) 2009
Müller (2019111822375024500_B26) 2008; 22
World Health Organization. (2019111822375024500_B14) 2006; 932
Olavarria (2019111822375024500_B24) 2001; 97
Hughes (2019111822375024500_B16) 2006; 20
Lion (2019111822375024500_B25) 1993; 341
Zhang (2019111822375024500_B6) 2007; 9
O'Brien (2019111822375024500_B1) 2009; 7
Gabert (2019111822375024500_B4) 2003; 17
Müller (2019111822375024500_B13) 2009; 23
Branford (2019111822375024500_B11) 2008; 112
Raanani (2019111822375024500_B22) 1997; 99
Baccarani (2019111822375024500_B2) 2009; 27
Müller (2019111822375024500_B7) 2007; 92
2019111822375024500_B17
Cross (2019111822375024500_B5) 2009; 22
Hughes (2019111822375024500_B8) 2006; 108
Hughes (2019111822375024500_B9) 2003; 349
Branford (2019111822375024500_B10) 2006; 20
Malinge (2019111822375024500_B23) 1992; 82
Saldanha (2019111822375024500_B15) 2007; 21
Emig (2019111822375024500_B20) 1999; 13
Cross (2019111822375024500_B18) 1994; 8
Hirsh (2019111822375024500_B12) 1994; 154
Branford (2019111822375024500_B19) 1999; 107
References_xml – volume: 97
  start-page: 1560
  year: 2001
  end-page: 1565
  ident: bib24
  article-title: Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia.
  publication-title: Blood
– volume: 20
  start-page: 1925
  year: 2006
  end-page: 1930
  ident: bib10
  article-title: Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia.
  publication-title: Leukemia
– volume: 341
  start-page: 275
  year: 1993
  end-page: 276
  ident: bib25
  article-title: Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia.
  publication-title: Lancet
– volume: 21
  start-page: 1481
  year: 2007
  end-page: 1487
  ident: bib15
  article-title: Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements.
  publication-title: Leukemia
– volume: 13
  start-page: 1825
  year: 1999
  end-page: 1832
  ident: bib20
  article-title: Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.
  publication-title: Leukemia
– volume: 8
  start-page: 186
  year: 1994
  end-page: 189
  ident: bib18
  article-title: An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders.
  publication-title: Leukemia
– volume: 91
  start-page: 126
  year: 1995
  end-page: 131
  ident: bib21
  article-title: Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.
  publication-title: Br J Haematol
– volume: 349
  start-page: 1423
  year: 2003
  end-page: 1432
  ident: bib9
  article-title: Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
  publication-title: N Engl J Med
– volume: 9
  start-page: 421
  year: 2007
  end-page: 430
  ident: bib6
  article-title: Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.
  publication-title: J Mol Diagn
– volume: 7
  start-page: 984
  year: 2009
  end-page: 1023
  ident: bib1
  article-title: NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.
  publication-title: J Natl Compr Canc Netw
– volume: 20
  start-page: 29
  year: 2006
  end-page: 41
  ident: bib16
  article-title: Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
  publication-title: Blood Rev
– start-page: 371
  year: 2009
  end-page: 381
  ident: bib3
  article-title: Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
  publication-title: Hematology Am Soc Hematol Educ Program
– volume: 22
  start-page: 355
  year: 2009
  end-page: 365
  ident: bib5
  article-title: Standardisation of molecular monitoring for chronic myeloid leukaemia.
  publication-title: Best Pract Res Clin Haematol
– volume: 99
  start-page: 945
  year: 1997
  end-page: 950
  ident: bib22
  article-title: The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation.
  publication-title: Br J Haematol
– volume: 22
  start-page: 96
  year: 2008
  end-page: 102
  ident: bib26
  article-title: Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.
  publication-title: Leukemia
– volume: 932
  start-page: 1
  year: 2006
  end-page: 137
  ident: bib14
  article-title: WHO Expert Committee on Biological Standardization.
  publication-title: World Health Organization Technical Report Series
– volume: 154
  start-page: 282
  year: 1994
  end-page: 288
  ident: bib12
  article-title: The international normalized ratio. A guide to understanding and correcting its problems.
  publication-title: Arch Intern Med
– volume: 108
  start-page: 28
  year: 2006
  end-page: 37
  ident: bib8
  article-title: Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
  publication-title: Blood
– volume: 27
  start-page: 6041
  year: 2009
  end-page: 6051
  ident: bib2
  article-title: Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
  publication-title: J Clin Oncol
– volume: 82
  start-page: 701
  year: 1992
  end-page: 707
  ident: bib23
  article-title: Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy.
  publication-title: Br J Haematol
– volume: 107
  start-page: 587
  year: 1999
  end-page: 599
  ident: bib19
  article-title: Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics.
  publication-title: Br J Haematol
– volume: 17
  start-page: 2318
  year: 2003
  end-page: 2357
  ident: bib4
  article-title: Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
  publication-title: Leukemia
– volume: 92
  start-page: 970
  year: 2007
  end-page: 973
  ident: bib7
  article-title: An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.
  publication-title: Haematologica
– reference: White HE, Cross NCP, Freeze dried cell lines as reference materials for standardisation of BCR-ABL RQPCR methods: report of a field trial evaluation., Accessed June 23, 2010, 1-53. 2008. www.ngrl.org.uk/Wessex/downloads/pdf/NGRLW_NIBSC_BCR_ABL_1.0.pdf.
– volume: 23
  start-page: 1957
  year: 2009
  end-page: 1963
  ident: bib13
  article-title: Harmonization of molecular monitoring of CML therapy in Europe.
  publication-title: Leukemia
– volume: 112
  start-page: 3330
  year: 2008
  end-page: 3338
  ident: bib11
  article-title: Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.
  publication-title: Blood
– start-page: 371
  year: 2009
  ident: 2019111822375024500_B3
  article-title: Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
  publication-title: Hematology Am Soc Hematol Educ Program
  doi: 10.1182/asheducation-2009.1.371
– volume: 9
  start-page: 421
  issue: 4
  year: 2007
  ident: 2019111822375024500_B6
  article-title: Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.
  publication-title: J Mol Diagn
  doi: 10.2353/jmoldx.2007.060134
– volume: 97
  start-page: 1560
  issue: 6
  year: 2001
  ident: 2019111822375024500_B24
  article-title: Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia.
  publication-title: Blood
  doi: 10.1182/blood.V97.6.1560
– volume: 932
  start-page: 1
  issue: v-vi
  year: 2006
  ident: 2019111822375024500_B14
  article-title: WHO Expert Committee on Biological Standardization.
  publication-title: World Health Organization Technical Report Series
– volume: 27
  start-page: 6041
  issue: 35
  year: 2009
  ident: 2019111822375024500_B2
  article-title: Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.25.0779
– volume: 20
  start-page: 29
  issue: 1
  year: 2006
  ident: 2019111822375024500_B16
  article-title: Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
  publication-title: Blood Rev
  doi: 10.1016/j.blre.2005.01.008
– volume: 108
  start-page: 28
  issue: 1
  year: 2006
  ident: 2019111822375024500_B8
  article-title: Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
  publication-title: Blood
  doi: 10.1182/blood-2006-01-0092
– volume: 23
  start-page: 1957
  issue: 11
  year: 2009
  ident: 2019111822375024500_B13
  article-title: Harmonization of molecular monitoring of CML therapy in Europe.
  publication-title: Leukemia
  doi: 10.1038/leu.2009.168
– volume: 154
  start-page: 282
  issue: 3
  year: 1994
  ident: 2019111822375024500_B12
  article-title: The international normalized ratio. A guide to understanding and correcting its problems.
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.1994.00420030084008
– volume: 112
  start-page: 3330
  issue: 8
  year: 2008
  ident: 2019111822375024500_B11
  article-title: Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.
  publication-title: Blood
  doi: 10.1182/blood-2008-04-150680
– volume: 22
  start-page: 355
  issue: 3
  year: 2009
  ident: 2019111822375024500_B5
  article-title: Standardisation of molecular monitoring for chronic myeloid leukaemia.
  publication-title: Best Pract Res Clin Haematol
  doi: 10.1016/j.beha.2009.04.001
– volume: 8
  start-page: 186
  issue: 1
  year: 1994
  ident: 2019111822375024500_B18
  article-title: An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders.
  publication-title: Leukemia
– volume: 22
  start-page: 96
  issue: 1
  year: 2008
  ident: 2019111822375024500_B26
  article-title: Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404983
– volume: 7
  start-page: 984
  issue: 9
  year: 2009
  ident: 2019111822375024500_B1
  article-title: NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.
  publication-title: J Natl Compr Canc Netw
  doi: 10.6004/jnccn.2009.0065
– volume: 349
  start-page: 1423
  issue: 15
  year: 2003
  ident: 2019111822375024500_B9
  article-title: Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa030513
– ident: 2019111822375024500_B17
– volume: 91
  start-page: 126
  issue: 1
  year: 1995
  ident: 2019111822375024500_B21
  article-title: Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.1995.tb05257.x
– volume: 82
  start-page: 701
  issue: 4
  year: 1992
  ident: 2019111822375024500_B23
  article-title: Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy.
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.1992.tb06947.x
– volume: 341
  start-page: 275
  issue: 8840
  year: 1993
  ident: 2019111822375024500_B25
  article-title: Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia.
  publication-title: Lancet
  doi: 10.1016/0140-6736(93)92619-5
– volume: 20
  start-page: 1925
  issue: 11
  year: 2006
  ident: 2019111822375024500_B10
  article-title: Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia.
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404388
– volume: 99
  start-page: 945
  issue: 4
  year: 1997
  ident: 2019111822375024500_B22
  article-title: The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation.
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.1997.4683272.x
– volume: 92
  start-page: 970
  issue: 7
  year: 2007
  ident: 2019111822375024500_B7
  article-title: An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR.
  publication-title: Haematologica
  doi: 10.3324/haematol.11172
– volume: 107
  start-page: 587
  year: 1999
  ident: 2019111822375024500_B19
  article-title: Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics.
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.1999.01749.x
– volume: 13
  start-page: 1825
  issue: 11
  year: 1999
  ident: 2019111822375024500_B20
  article-title: Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2401566
– volume: 21
  start-page: 1481
  issue: 7
  year: 2007
  ident: 2019111822375024500_B15
  article-title: Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements.
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404716
– volume: 17
  start-page: 2318
  issue: 12
  year: 2003
  ident: 2019111822375024500_B4
  article-title: Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2403135
SSID ssj0014325
Score 2.4027016
Snippet Serial quantitation of BCR-ABL mRNA levels is an important indicator of therapeutic response for patients with chronic myelogenous leukemia and Philadelphia...
SourceID swepub
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e111
SubjectTerms Abl protein
Acute lymphatic leukemia
BCR protein
Blood
Cell Line
Chromosome translocations
Chronic myeloid leukemia
Fusion protein
Fusion Proteins, bcr-abl - genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
MEDICIN
MEDICINE
mRNA
Polymerase chain reaction
Quantitation
Reference Standards
Reverse Transcriptase Polymerase Chain Reaction - methods
Reverse Transcriptase Polymerase Chain Reaction - standards
RNA, Messenger - genetics
Standardization
World Health Organization
Title Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
URI https://dx.doi.org/10.1182/blood-2010-06-291641
https://www.ncbi.nlm.nih.gov/pubmed/20720184
https://www.proquest.com/docview/814466007
https://www.proquest.com/docview/954593213
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-139355
Volume 116
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEJcXBB2XcpMfgBeUkjr3x7QMpsEmqDa0NytJnanbmkwjQQL-POfYJ1nTrRrwEkWJ40T5vjjfsc-FsVcicwIxsx1LgVq33ChTVqrCzHKVbydpmihb6Wyfe_72gbtz6B32ej-WvJbqKh1mv66MK_kfVOEY4IpRsv-AbNspHIB9wBe2gDBs_wrjLZB2ehapWdFHFZnPQdCRkwwFGS0HXK7MAWLa6Uo70zcJZ78khdJBjRhwWVSUwxt7H0-mVjz-_HYx3Ys7i8GnVHF-uFxxT__QLgIddkHUHldgS9cnqx6J0_kRJfjseAt_TFIKKNpRxGGankBXj5FlQpmHioZUzIFtC7sz5poASyKXiUymIVTR6Ht5bA8xV6zx5zdr-L4lQN26neaA0NlC4y3sAJqZAnQrObWbUzfYTQHmBY6Pn75erD65jvAozBJu-u6qW2ISaepknaK5bLGspKPVEmb_PrtHtgePDZEesJ4q-mwzBi6Ui5_8DdfewHqZpc9ujZu9O5OmJmCf3d4lV4xN9rtDPl7mHMjHNfm4Jh835OPL5OMd8nEiH2_JxzX5OJCPL5MPeyfycSTfQ3bwYWt_sm1RJQ8r81xRwZcfzWZeAuo0TDwR5IEHv9VcuTmITRgVMl-5IMMzGw55YMH6ueNEYQDSOUuwNoxyHrGNoizUE8Yxo2OOBWLyPIQtNEsiEWIVgdCdJY4_YE6DhszoKbHayqnU5m4opIZTIpzS9qWBc8Cs9qozk-blmvZBA7QkqWokqAS2XnMlb3ghATxcnoM3W9bfZYhTM1guYn2TCOwdMLhGzoA9NpRqn7Zh44C9Nhxrz2AC-ffzb7Esz49kXcsRRuN7T9f28IzdbT5ke_ScbVTntXoByrtKX-rP5A8XHtWU
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Establishment+of+the+first+World+Health+Organization+International+Genetic+Reference+Panel+for+quantitation+of+BCR-ABL+mRNA&rft.jtitle=Blood&rft.au=White%2C+Helen+E&rft.au=Matejtschuk%2C+Paul&rft.au=Rigsby%2C+Peter&rft.au=Gabert%2C+Jean&rft.date=2010-11-25&rft.eissn=1528-0020&rft.volume=116&rft.issue=22&rft.spage=e111&rft_id=info:doi/10.1182%2Fblood-2010-06-291641&rft_id=info%3Apmid%2F20720184&rft.externalDocID=20720184
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon